Molecular mechanisms underlying human synovial sarcoma development

Genes Chromosomes and Cancer

Volumn 30, Issue 1, 2001, Pages 1-14

  dos Santos, Nuno R ^a,b   de Bruijn, Diederik R H ^a   van Kessel, Ad Geurts ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TUMOR PROTEIN;

CARCINOGENESIS; CELL NUCLEUS; CHROMOSOME 18; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; DIFFERENTIAL DIAGNOSIS; GENE FUSION; HISTOPATHOLOGY; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SYNOVIAL SARCOMA; TRANSCRIPTION REGULATION; X CHROMOSOME;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0035209129     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G     Document Type: Review

References (110)

1. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications
2. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma
3. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases
4. Developmental changes in methylation of spermatogenesis-specific genes include reprogramming in the epididymis
5. Synovial sarcoma. Identification of low and high risk groups
6. Synovial sarcoma of the upper digestive tract: A report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization
7. Synovial sarcoma specific translocation associated with both epithelial and spindle cell components
8. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies
9. Tendosynovial sarcoma: Clinicopathologic features, treatment, and prognosis
10. Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII)
11. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma
12. Synovial sarcoma of bone delineated by spectral karyotyping
13. Synovial sarcoma mimicking desmoplastic small round-cell tumor: Critical role for molecular diagnosis
14. Fusion of SYT to two genes SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma
15. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas
16. Sublocalization of the svnovial sarcoma-associated t(X;18) chromosomal breakpoint in Xp11.2 using cosmid cloning and fluorescence in situ hybridization
17. Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: Relationship to histologic subtypes
18. Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2;q11.2) breakpoint
19. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas
20. A novel Kruppel-associated box containing SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas
21. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
22. Delineation of the protein domains responsible for SYT, SSX and SYT-SSX nuclear localization
23. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines
24. Synovial sarcoma: Ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors
25. Synovial sarcoma
26. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript
27. Poorly differentiated synovial sarcoma: Immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors
28. Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience
29. Masked t(X;18)(p11;q11) in a biphasic synovial sarcoma revealed by FISH and RT-PCR
30. SSX: A multigene family with several members transcribed in normal testis and human cancer
31. Mammalian Trithorax and Polycomb-group homologues are antagonistic regulators of homeotic development
32. Biphasic synovial sarcoma in the small intestinal mesentery
33. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: Analyses of 84 soft tissue and bone tumors
34. Primary synovial sarcoma of the lung: Report of two cases confirmed by molecular detection of SYT-SSX fusion gene transcripts
35. Detection of SYT-SSX fusion transcript in synovial sarcoma using archival cytologic specimens
36. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma
37. Inrerphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma
38. Synovial sarcoma: A study of intensive chemotherapy in 14 patients with localized disease
39. Biphasic synovial sarcoma of the peritoneal cavity with t(X;18) demonstrated by reverse transcriptase polymerase chain reaction
40. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma
41. The polycomb and trithorax group proteins of Drosophila: Trans-regulators of homeotic gene function
42. Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization
43. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: A reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma
44. Ber-Ep4: A new monoclonal antibody which distinguishes epithelia from mesothelia
45. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas
46. Translocations involving the X chromosome in solid tumors: Presentation of two sarcomas with t(X;18)(q13;p11)
47. Cytogenetics of synovial sarcoma: Presentation of ten new cases and review of the literature
48. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation
49. Synovial sarcoma: Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
50. Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: A diagnostic and prognostic aid for synovial sarcoma
51. Synovial sarcoma of the extremities: A clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas
52. Nonrandom secondary chromosome aberration in synovial sarcoma with t(X;18)
53. Kruppel-associated boxes are potent transcriptional repression domains
54. Polyproline, beta-turn helices. Novel secondary structures proposed for the tandem repeats within rhodopsin, synaptophysin, synexin, gliadin, RNA polymerase II, hordein, and gluten
55. Keratin subsets in spindle cell sarcomas: Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins
56. Cell-type and tumor type-related patterns of Bcl2 reactivity in mesenchymal cells and soft tissue tumors
57. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins
58. Chromosomal analysis and the classification of soft tissue sarcomas
59. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor
60. ATP-dependent chromatin remodelling: SWI/SNF and co. are on the job
61. Chromosomal translocation t(X;18) in human synovial sarcomas analyzed by fluorescence in situ hybridization using paraffin-embedded tissue
62. Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: A clinicopathological and immunohistochemical review of three cases
63. Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma
64. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome
65. Establishment and characterization of a new synovial sarcoma cell line, SN-SY-1: Special reference to bcl-2 protein and SYT-SSX1 hybrid transcripts
66. Translocation (X;18) in a biphasic synovial sarcoma with morphological features of neural differentiation
67. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma
68. Survival in synovial sarcoma: A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival
69. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma
70. Primary pericardial synovial sarcoma with detection of the chimeric transcript SYT-SSX
71. A synovial sarcoma with a complex t(X;18;5;4) and a break in the ornithine aminotransferase (OAT)L1 cluster on Xp11.2
72. SH2 and SH3 domains
73. Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization
74. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma
75. Synovial sarcoma: Uniform response of metastases to high dose ifosfamide
76. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex
77. Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript
78. Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma
79. Polycomb group protein complexes: Do different complexes regulate distinct target genes?
80. The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain
81. Stabilization of chromatin structure by PRC1, a polycomb complex
82. The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome
83. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma
84. Synovial sarcoma: Prognostic significance of tumor size, margin of resection, and mitotic activity for survival
85. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization
86. A novel fusion gene, SYT-SSX4, in synovial sarcoma
87. Ki-67 is strongly prognostic in synovial sarcoma: Analysis based on 86 patients from the Scandinavian Sarcoma Group Register
88. Synovial sarcomas lack synovial differentiation
89. A consistent chromosome translocation in synovial sarcoma
90. A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 gene
91. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex
92. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
93. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization
94. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and colocalization with the SNF protein BRM in the nucleus
95. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice
96. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues
97. Translocation X;18 in synovial sarcoma
98. The SSX-2 gene, which is involved in the t(X,18) translocation of synovial sarcomas, codes for the human tumor antigen HOMMEL 40
99. Expression of SSX genes in human tumors
100. Synovial sarcoma: Oncological and functional results
101. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma
102. Poorly differentiated synovial sarcoma: An analysis of clinical, pathologic and molecular genetic features
103. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex
104. Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma
105. The Kruppel-associated box-A (KRAB-A) domain of zinc-finger proteins mediates transcriptional repression
106. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype
107. Dual-colour fluorescence in situ hybridization analysis of synovial sarcoma